|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
4
|
Tan Z, Liu X, Yu E, Wang H, Tang L, Wang H
and Fu C: Lentivirus-mediated RNA interference of tripartite motif
68 inhibits the proliferation of colorectal cancer cell lines
SW1116 and HCT11 in vitro. Oncol Lett. 13:2649–2655. 2017.
View Article : Google Scholar :
|
|
5
|
Ribero D, Viganò L, Amisano M and
Capussotti L: Prognostic factors after resection of colorectal
liver metastases: From morphology to biology. Future Oncol.
9:45–57. 2013. View Article : Google Scholar
|
|
6
|
Nakamura T, Saito H and Takekawa M: SAPK
pathways and p53 cooperatively regulate PLK4 activity and
centrosome integrity under stress. Nat Commun. 4:17752013.
View Article : Google Scholar
|
|
7
|
Xu X, Huang S, Zhang B, Huang F, Chi W, Fu
J, Wang G, Li S, Jiang Q and Zhang C: DNA replication licensing
factor Cdc6 and Plk4 kinase antagonistically regulate centrosome
duplication via Sas-6. Nat Commun. 8:151642017. View Article : Google Scholar :
|
|
8
|
Rosario CO, Ko MA, Haffani YZ, Gladdy RA,
Paderova J, Pollett A, Squire JA, Dennis JW and Swallow CJ: Plk4 is
required for cytokinesis and maintenance of chromosomal stability.
Proc Natl Acad Sci USA. 107:6888–6893. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fischer M, Quaas M, Wintsche A, Müller GA
and Engeland K: Polo-like kinase 4 transcription is activated via
CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and
deregulated by HPV E7 protein. Nucleic Acids Res. 42:163–180. 2014.
View Article : Google Scholar
|
|
10
|
Rosario CO, Kazazian K, Zih FS,
Brashavitskaya O, Haffani Y, Xu RS, George A, Dennis JW and Swallow
CJ: A novel role for Plk4 in regulating cell spreading and
motility. Oncogene. 34:3441–3451. 2015. View Article : Google Scholar
|
|
11
|
Kazazian K, Go C, Wu H, Brashavitskaya O,
Xu R, Dennis JW, Gingras AC and Swallow CJ: Plk4 Promotes Cancer
Invasion and Metastasis through Arp2/3 Complex Regulation of the
Actin Cytoskeleton. Cancer Res. 77:434–447. 2017. View Article : Google Scholar
|
|
12
|
Kawakami M, Mustachio LM, Zheng L, Chen Y,
Rodriguez-Canales J, Mino B, Kurie JM, Roszik J, Villalobos PA, Thu
KL, et al: Polo-like kinase 4 inhibition produces polyploidy and
apoptotic death of lung cancers. Proc Natl Acad Sci USA.
115:1913–1918. 2018. View Article : Google Scholar
|
|
13
|
Tian X, Zhou D, Chen L, Tian Y, Zhong B,
Cao Y, Dong Q, Zhou M, Yan J, Wang Y, et al: Polo-like kinase 4
mediates epithelial-mesenchymal transition in neuroblastoma via
PI3K/Akt signaling pathway. Cell Death Dis. 9:542018. View Article : Google Scholar
|
|
14
|
Li Z, Dai K, Wang C, Song Y, Gu F, Liu F
and Fu L: Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer
and Its Response to Taxane-Based Neoadjuvant Chemotherapy. J
Cancer. 7:1125–1132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Korzeniewski N, Hohenfellner M and
Duensing S: CAND1 promotes PLK4-mediated centriole overduplication
and is frequently disrupted in prostate cancer. Neoplasia.
14:799–806. 2012. View Article : Google Scholar
|
|
16
|
Li L and Li W: Epithelial-mesenchymal
transition in human cancer: Comprehensive reprogramming of
metabolism, epigenetics, and differentiation. Pharmacol Ther.
150:33–46. 2015. View Article : Google Scholar
|
|
17
|
Qi J, Yu Y, Akilli Öztürk Ö, Holland JD,
Besser D, Fritzmann J, Wulf-Goldenberg A, Eckert K, Fichtner I and
Birchmeier W: New Wnt/β-catenin target genes promote experimental
metastasis and migration of colorectal cancer cells through
different signals. Gut. 65:1690–1701. 2016. View Article : Google Scholar
|
|
18
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar
|
|
19
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Ding ZY, Jin GN, Wang W, Chen WX, Wu YH,
Ai X, Chen L, Zhang WG, Liang HF, Laurence A, et al: Reduced
expression of transcriptional intermediary factor 1 gamma promotes
metastasis and indicates poor prognosis of hepatocellular
carcinoma. Hepatology. 60:1620–1636. 2014. View Article : Google Scholar
|
|
22
|
Guide for the Care and Use of Laboratory
Animals. NIH Publication No. pp. 85–23. National Academies Press
(US); Washington, DC: 1985
|
|
23
|
Godinho SA, Picone R, Burute M, Dagher R,
Su Y, Leung CT, Polyak K, Brugge JS, Théry M and Pellman D:
Oncogene-like induction of cellular invasion from centrosome
amplification. Nature. 510:167–171. 2014. View Article : Google Scholar
|
|
24
|
Coelho PA, Bury L, Shahbazi MN,
Liakath-Ali K, Tate PH, Wormald S, Hindley CJ, Huch M, Archer J,
Skarnes WC, et al: Overexpression of Plk4 induces centrosome
amplification, loss of primary cilia and associated tissue
hyperplasia in the mouse. Open Biol. 5:1502092015. View Article : Google Scholar
|
|
25
|
Bakhoum SF, Ngo B, Laughney AM, Cavallo
JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, et
al: Chromosomal instability drives metastasis through a cytosolic
DNA response. Nature. 553:467–472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gulluni F, Martini M, De Santis MC, Campa
CC, Ghigo A, Margaria JP, Ciraolo E, Franco I, Ala U, Annaratone L,
et al: Mitotic Spindle Assembly and Genomic Stability in Breast
Cancer Require PI3K-C2 α Scaffolding Function. Cancer Cell.
32:444–459.e7. 2017. View Article : Google Scholar
|
|
27
|
Pellegrino R, Calvisi DF, Ladu S, Ehemann
V, Staniscia T, Evert M, Dombrowski F, Schirmacher P and Longerich
T: Oncogenic and tumor suppressive roles of polo-like kinases in
human hepatocellular carcinoma. Hepatology. 51:857–868. 2010.
|
|
28
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar
|
|
29
|
Nusse R and Clevers H: Wnt/β-Catenin
Signaling, Disease, and Emerging Therapeutic Modalities. Cell.
169:985–999. 2017. View Article : Google Scholar
|
|
30
|
Ferrarelli LK: Treating WNT-driven
colorectal cancer. Science. 356:1346–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar
|
|
32
|
Singh M, Yelle N, Venugopal C and Singh
SK: EMT: Mechanisms and therapeutic implications. Pharmacol Ther.
182:80–94. 2018. View Article : Google Scholar
|
|
33
|
Sun Y, Ji B, Feng Y, Zhang Y, Ji D, Zhu C,
Wang S, Zhang C, Zhang D and Sun Y: TRIM59 facilitates the
proliferation of colorectal cancer and promotes metastasis via the
PI3K/AKT pathway. Oncol Rep. 38:43–52. 2017. View Article : Google Scholar
|
|
34
|
Brabletz T, Jung A, Reu S, Porzner M,
Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable
beta-catenin expression in colorectal cancers indicates tumor
progression driven by the tumor environment. Proc Natl Acad Sci
USA. 98:10356–10361. 2001. View Article : Google Scholar
|
|
35
|
Xie SL, Fan S, Zhang SY, Chen WX, Li QX,
Pan GK, Zhang HQ, Wang WW, Weng B, Zhang Z, et al: SOX8 regulates
cancer stem-like properties and cisplatin-induced EMT in tongue
squamous cell carcinoma by acting on the Wnt/β-catenin pathway. Int
J Cancer. 142:1252–1265. 2018. View Article : Google Scholar
|
|
36
|
Zhang Q, Li Y, Zhao R, Wang X, Fan C, Xu
Y, Liu Y, Li J and Wang S: The gain-of-function mutation E76K in
SHP2 promotes CAC tumorigenesis and induces EMT via the
Wnt/β-catenin signaling pathway. Mol Carcinog. 57:619–628. 2018.
View Article : Google Scholar : PubMed/NCBI
|
